Portable breathing device for severe COPD
Part of Lungs & breathing clinical trials.
This trial tests a portable device that delivers gentle air pressure to help you breathe easier. It is for people with severe COPD (chronic obstructive pulmonary disease) who want to see if this device can improve their breathing and daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 85 years old.
- You have stable health (no sudden flare-ups).
- You have been diagnosed with severe COPD, meaning your FEV1 (a measure of lung function) is between 30% and 50% of what is expected.
- You can walk or stand without help.
- You speak and understand English well enough to follow instructions.
- You are willing to participate and follow the study plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of breathing exercise devices to see which one helps people with COPD improve their breathing. You will use one of the devices during the study, and your lung function will be measured to see how well it works.
This trial studies whether using a handheld breathing device (called a PEP buddy) helps people with COPD feel less short of breath. It also looks at how the device may work to improve breathing during daily activities.
This study tests two breathing support methods—one using a mask and one using a small device—to see if they help people with severe COPD breathe better. You may join if you are over 40 and have stage 3 or 4 COPD.
This study tests whether a new approach can help relieve severe shortness of breath in people with COPD who are already on standard inhaler therapy. It may help you breathe easier and improve your daily life.
This study tests whether using a breathing machine (called non-invasive ventilation, or BiPAP) at home can help people with severe COPD breathe better and possibly live longer. It is for people whose blood CO2 levels stay high even after a COPD flare-up.
This trial tests an implantable artificial bronchus to help people with severe emphysema breathe easier. It's for those who have stable COPD, can walk 100–400 meters in 6 minutes, and haven't smoked for at least 4 months.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.